Clinical Characteristics and Outcomes in Patients Diagnosed With Novel Influenza A (H1N1)
NCT01024673 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 38
Last updated 2021-08-23
Summary
This is study where medical record information will be collected as well as collection of excess biological samples.
Conditions
Sponsors & Collaborators
-
University of Pittsburgh
lead OTHER
Principal Investigators
-
Fernanda Silveira, MD · University of Pittsburgh
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2009-10-15
- Primary Completion
- 2021-08-19
- Completion
- 2021-08-19
Countries
- United States
Study Locations
More Related Trials
-
Virus Shedding and Environmental Deposition of a Novel Influenza Virus
NCT01046734 ·Status: COMPLETED
-
China Case Control Avian Influenza
NCT00428753 ·Status: COMPLETED
-
Dose, Safety, and Pathogenicity of a New Influenza H1N1 Challenge Strain
NCT05572450 ·Status: COMPLETED ·Phase: NA
-
Prospective Study of AI H5N1 in China
NCT00428493 ·Status: COMPLETED
-
H5N1 Mix and Match With MF59
NCT01317745 ·Status: COMPLETED ·Phase: PHASE1
-
Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine
NCT01023776 ·Status: COMPLETED ·Phase: PHASE4
-
Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
NCT01658800 ·Status: COMPLETED ·Phase: PHASE1
-
Inactivated Influenza A/H5N1 Vaccine in the Elderly
NCT00230750 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza
NCT05160636 ·Status: ACTIVE_NOT_RECRUITING
-
A Study to Look at the Health Outcomes of Patients With COVID-19 and Influenza.
NCT06163677 ·Status: WITHDRAWN
-
Respiratory Virus Hospitalization Study (FLU 003 Plus)
NCT01056185 ·Status: COMPLETED
-
Influenza in People With Normal and Weakened Immune Systems
NCT00533182 ·Status: COMPLETED
-
A/H5N1 Dose Ranging Study With Adjuvant Patch
NCT00532792 ·Status: COMPLETED ·Phase: PHASE1
-
Vaccine Responses to Influenza A H1N1/09 Immunization in High-risk Patients
NCT01022905 ·Status: COMPLETED ·Phase: PHASE4
-
Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Children Aged 6 to 35 Month
NCT01040078 ·Status: UNKNOWN ·Phase: PHASE3
-
Study to Evaluate the Immunogenicity and Safety of an Investigational Influenza Vaccine (H1N1) in Adults
NCT00951041 ·Status: COMPLETED ·Phase: PHASE2
-
Immunologic Response to Inactivated Vaccine for Novel H1N1 Virus
NCT01023711 ·Status: COMPLETED ·Phase: NA
-
Safety and Immunogenicity of Vaccine in Adults at Occupational Risk for Influenza A (H5N1) Exposure
NCT01045564 ·Status: WITHDRAWN ·Phase: PHASE2
-
Influenza Challenge Study in Healthy Volunteers
NCT02746211 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Long-term Observation of Hemagglutinin and Neuraminidase Inhibition Antibody Titers After Influenza Challenge
NCT02511002 ·Status: ENROLLING_BY_INVITATION
-
Safety and Immunogenicity of Two Doses of H5N1 Influenza Vaccine in Elderly Subjects
NCT01766921 ·Status: COMPLETED ·Phase: PHASE2
-
Collection and Extraction of Respiratory Specimens
NCT01083511 ·Status: COMPLETED
-
Observational Safety and Effectiveness Study of Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Egg Derived Vaccine
NCT01101074 ·Status: COMPLETED
-
From Innovation to Solutions: Childhood Influenza Vaccination Planning
NCT01664793 ·Status: COMPLETED ·Phase: NA
-
Influenza Antiviral DAS-181-F04 in Healthy Adults
NCT01651494 ·Status: COMPLETED ·Phase: PHASE1